# Endoscopic Nebulizing Device for Surgical Haemostatic-sealant Glubran® 2 Usability Trial in EMR and ESD

> **NCT06588881** · NA · COMPLETED · sponsor: **GEM SRL** · enrollment: 15 (actual)

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **DEVICE:** nebulized application of the haemostatic surgical sealant after gastrointestinal endoscopic resection

## Key facts

- **NCT ID:** NCT06588881
- **Lead sponsor:** GEM SRL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-14
- **Primary completion:** 2024-03-28
- **Final completion:** 2024-03-28
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06588881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06588881, "Endoscopic Nebulizing Device for Surgical Haemostatic-sealant Glubran® 2 Usability Trial in EMR and ESD". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT06588881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*